Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

Soliwoda-Doan was one of many Americans who had never even heard of H.B.V. There is no cure for hepatitis B, but it is ...

The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak ...

1 Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China 2 Department of Clinical Medicine, First College of Clinical Medicine, Binzhou Medical University, Yantai, ...

The company will evaluate the Hepzato kit as a combination therapy with the standard of care in patients with liver-dominant ...

WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news ...

Patients diagnosed with uveal melanoma, which once it has spread to major organs is almost always fatal, can now be offered the first-of-its-kind treatment, tebentafusp, following today’s approval by ...

Patients diagnosed with uveal melanoma, which once it has spread to major organs is almost always fatal, can now be offered the first-of-its-kind treatment, tebentafusp, following today’s ...

Patients with uveal melanoma face many threats: early death, pain, visual handicap, and facial disfigurement, which result in loss of income and independence, with restrictions on occupational ...

Patients diagnosed with uveal melanoma can now be offered the first-of-its-kind treatment, tebentafusp, following today’s approval by the National Institute for Health and Care Excellence (NICE). Over ...